(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 16.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.
Mainz Biomed Nv's earnings in 2025 is -$18,971,112.On average, 3 Wall Street analysts forecast MYNZ's earnings for 2025 to be -$16,277,391, with the lowest MYNZ earnings forecast at -$15,639,062, and the highest MYNZ earnings forecast at -$16,756,138. On average, 3 Wall Street analysts forecast MYNZ's earnings for 2026 to be -$7,846,537, with the lowest MYNZ earnings forecast at -$7,538,830, and the highest MYNZ earnings forecast at -$8,077,318.
In 2027, MYNZ is forecast to generate -$8,305,643 in earnings, with the lowest earnings forecast at -$7,979,932 and the highest earnings forecast at -$8,549,927.